Pseudomonas aeruginosa is capable of causing a variety of acute and chronic infections. Here, we provide evidence that sbrR (PA2895), a gene previously identified as required during chronic P. aeruginosa respiratory infection, encodes an anti-factor that inhibits the activity of its cognate extracytoplasmic-function factor, SbrI (PA2896). Bacterial two-hybrid analysis identified an N-terminal region of SbrR that interacts directly with SbrI and that was sufficient for inhibition of SbrI-dependent gene expression. We show that SbrI associates with RNA polymerase in vivo and identify the SbrIR regulon. In cells lacking SbrR, the SbrI-dependent expression of muiA was found to inhibit swarming motility and promote biofilm formation. Our findings reveal SbrR and SbrI as a novel set of regulators of swarming motility and biofilm formation in P. aeruginosa that mediate their effects through muiA, a gene not previously known to influence surface-associated behaviors in this organism.
IMPORTANCEThis study characterizes a factor/anti-factor system that reciprocally regulates the surface-associated behaviors of swarming motility and biofilm formation in the opportunistic pathogen Pseudomonas aeruginosa. We present evidence that SbrR is an anti-factor specific for its cognate factor, SbrI, and identify the SbrIR regulon in P. aeruginosa. We find that cells lacking SbrR are severely defective in swarming motility and exhibit enhanced biofilm formation. Moreover, we identify muiA (PA1494) as the SbrI-dependent gene responsible for mediating these effects. SbrIR have been implicated in virulence and in responding to antimicrobial and cell envelope stress. SbrIR may therefore represent a stress response system that influences the surface behaviors of P. aeruginosa during infection.T he Gram-negative bacterium Pseudomonas aeruginosa is an opportunistic human pathogen notorious for being the principal cause of morbidity and mortality in cystic fibrosis (CF) patients (1). In patients with CF, chronic pulmonary colonization by P. aeruginosa leads to chronic inflammation, progressive loss of lung function, and eventually respiratory failure and death (1). P. aeruginosa is also the fifth leading cause of nosocomial infections overall in the United States and is the second most common cause of ventilator-associated pneumonia (VAP) and catheter-associated urinary tract infections (CAUTI) (2, 3). In patients with VAP or CAUTI, P. aeruginosa grows as a biofilm on endotracheal tubes and catheters, respectively (4-6). In addition, P. aeruginosa is thought to persist as a biofilm in the CF lung (7). P. aeruginosa biofilms are associated with chronic infection and exhibit increased antibiotic resistance and resistance to clearance by the immune system (8). Thus, the ability to form biofilms contributes significantly to the clinical burden of P. aeruginosa infection.In P. aeruginosa, growth as a biofilm is inversely regulated with a cooperative form of multicellular surface motility called swarming (9-12). Swarming motility is flagell...